Graft-Versus-Host Disease (GVHD) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064934
  • May 2021
  • Biotechnology
  • 118 Pages
The Graft-Versus-Host Disease (GVHD) Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Novartis AG, Bristol-Myers Squibb, Pfizer, F. Hoffmann-La Roche, AbbVie, Astellas Pharma, Merck & Co, Takeda Pharmaceutical, Abbott, Eli Lilly.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Graft-Versus-Host Disease (GVHD) market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Graft-Versus-Host Disease (GVHD) market is expected to attain Pre COVID-19 levels by mid-2022.

Graft-Versus-Host Disease (GVHD) Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Graft-Versus-Host Disease (GVHD) market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Graft-Versus-Host Disease (GVHD) Market Competitive and Premeditated Analysis
In the Graft-Versus-Host Disease (GVHD) report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Graft-Versus-Host Disease (GVHD) research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Graft-Versus-Host Disease (GVHD) Market:
The Graft-Versus-Host Disease (GVHD) market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Novartis AG, Bristol-Myers Squibb, Pfizer, F. Hoffmann-La Roche, AbbVie, Astellas Pharma, Merck & Co, Takeda Pharmaceutical, Abbott, Eli Lilly.

The Graft-Versus-Host Disease (GVHD) market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Graft-Versus-Host Disease (GVHD) Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Graft-Versus-Host Disease (GVHD) market:
By Product Type
Corticosteroids
ATG therapies
IL2Ra
CD25 inhibitors
TNFa inhibitors
Calcineurin inhibitors
mTOR inhibitors
SOT therapies
Anti-neoplastic therapies
Stem Cell Treatments
Extracorporeal Photophoresis
Other biologics
Treatment Type
Prophylaxis GVHD
Chronic GVHD
Acute GVHD
End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regional Analysis of the Graft-Versus-Host Disease (GVHD) market:
The Graft-Versus-Host Disease (GVHD) market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Graft-Versus-Host Disease (GVHD) report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Graft-Versus-Host Disease (GVHD) market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Graft-Versus-Host Disease (GVHD) market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Graft-Versus-Host Disease (GVHD) market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Graft-Versus-Host Disease (GVHD) market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Graft-Versus-Host Disease (GVHD) market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Graft-Versus-Host Disease (GVHD) market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Graft-Versus-Host Disease (GVHD) market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Graft-Versus-Host Disease (GVHD) market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Novartis AG
  • Bristol-Myers Squibb
  • Pfizer
  • F. Hoffmann-La Roche
  • AbbVie
  • Astellas Pharma
  • Merck & Co
  • Takeda Pharmaceutical
  • Abbott
  • Eli Lilly.
  • Corticosteroids
  • ATG therapies
  • IL2Ra
  • CD25
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Graft-Versus-Host Disease (GVHD) Market Snapshot
          2.1.1. Global Graft-Versus-Host Disease (GVHD) Market By Product Type,2019
               2.1.1.1.Corticosteroids
               2.1.1.2.ATG therapies
               2.1.1.3.IL2Ra
               2.1.1.4.CD25
          2.1.2. Global Graft-Versus-Host Disease (GVHD) Market By End User,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Online Pharmacies
          2.1.3. Global Graft-Versus-Host Disease (GVHD) Market By End-use,2019
          2.1.4. Global Graft-Versus-Host Disease (GVHD) Market By Geography,2019

3. Global Graft-Versus-Host Disease (GVHD) Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Type, 2020
     4.2. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028

5. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028

6. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028

7. Global Graft-Versus-Host Disease (GVHD) Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Graft-Versus-Host Disease (GVHD) Market Analysis, 2018 – 2028 
          7.2.1. North America Graft-Versus-Host Disease (GVHD) Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028
          7.2.3. North America Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Graft-Versus-Host Disease (GVHD) Market Analysis, 2018 – 2028 
          7.3.1.  Europe Graft-Versus-Host Disease (GVHD) Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028
          7.3.3. Europe Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Graft-Versus-Host Disease (GVHD) Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Graft-Versus-Host Disease (GVHD) Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028
          7.4.3. Asia Pacific Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Graft-Versus-Host Disease (GVHD) Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Graft-Versus-Host Disease (GVHD) Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028
          7.5.3. Latin America Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Graft-Versus-Host Disease (GVHD) Market Analysis, 2018 – 2028 
          7.6.1.  MEA Graft-Versus-Host Disease (GVHD) Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Graft-Versus-Host Disease (GVHD) Market Size (US$), By Product Type, 2018 – 2028
          7.6.3. MEA Graft-Versus-Host Disease (GVHD) Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Graft-Versus-Host Disease (GVHD) Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Graft-Versus-Host Disease (GVHD) Providers
        8.4.1 Novartis AG
                8.4.1.1 Business Description
                8.4.1.2 Novartis AG Geographic Operations
                8.4.1.3 Novartis AG Financial Information
                8.4.1.4 Novartis AG Product Positions/Portfolio
                8.4.1.5 Novartis AG Key Developments
        8.4.2 Bristol-Myers Squibb
                8.4.2.1 Business Description
                8.4.2.2 Bristol-Myers Squibb Geographic Operations
                8.4.2.3 Bristol-Myers Squibb Financial Information
                8.4.2.4 Bristol-Myers Squibb Product Positions/Portfolio
                8.4.2.5 Bristol-Myers Squibb Key Developments
        8.4.3 Pfizer
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Geographic Operations
                8.4.3.3 Pfizer Financial Information
                8.4.3.4 Pfizer Product Positions/Portfolio
                8.4.3.5 Pfizer Key Developments
        8.4.4 F. Hoffmann-La Roche
                8.4.4.1 Business Description
                8.4.4.2 F. Hoffmann-La Roche Geographic Operations
                8.4.4.3 F. Hoffmann-La Roche Financial Information
                8.4.4.4 F. Hoffmann-La Roche Product Positions/Portfolio
                8.4.4.5 F. Hoffmann-La Roche Key Developments
        8.4.5 AbbVie
                8.4.5.1 Business Description
                8.4.5.2 AbbVie Geographic Operations
                8.4.5.3 AbbVie Financial Information
                8.4.5.4 AbbVie Product Positions/Portfolio
                8.4.5.5 AbbVie Key Developments
        8.4.6 Astellas Pharma
                8.4.6.1 Business Description
                8.4.6.2 Astellas Pharma Geographic Operations
                8.4.6.3 Astellas Pharma Financial Information
                8.4.6.4 Astellas Pharma Product Positions/Portfolio
                8.4.6.5 Astellas Pharma Key Developments
        8.4.7 Merck & Co
                8.4.7.1 Business Description
                8.4.7.2 Merck & Co Geographic Operations
                8.4.7.3 Merck & Co Financial Information
                8.4.7.4 Merck & Co Product Positions/Portfolio
                8.4.7.5 Merck & Co Key Developments
        8.4.8 Takeda Pharmaceutical
                8.4.8.1 Business Description
                8.4.8.2 Takeda Pharmaceutical Geographic Operations
                8.4.8.3 Takeda Pharmaceutical Financial Information
                8.4.8.4 Takeda Pharmaceutical Product Positions/Portfolio
                8.4.8.5 Takeda Pharmaceutical Key Developments
        8.4.9 Abbott
                8.4.9.1 Business Description
                8.4.9.2 Abbott Geographic Operations
                8.4.9.3 Abbott Financial Information
                8.4.9.4 Abbott Product Positions/Portfolio
                8.4.9.5 Abbott Key Developments
        8.4.10 Eli Lilly.
                8.4.10.1 Business Description
                8.4.10.2 Eli Lilly. Geographic Operations
                8.4.10.3 Eli Lilly. Financial Information
                8.4.10.4 Eli Lilly. Product Positions/Portfolio
                8.4.10.5 Eli Lilly. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Graft-Versus-Host Disease (GVHD) Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Graft-Versus-Host Disease (GVHD) Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Graft-Versus-Host Disease (GVHD) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Graft-Versus-Host Disease (GVHD) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Graft-Versus-Host Disease (GVHD) Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Graft-Versus-Host Disease (GVHD) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Graft-Versus-Host Disease (GVHD) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Graft-Versus-Host Disease (GVHD) Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Graft-Versus-Host Disease (GVHD) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Graft-Versus-Host Disease (GVHD) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Graft-Versus-Host Disease (GVHD) Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Graft-Versus-Host Disease (GVHD) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Graft-Versus-Host Disease (GVHD) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Graft-Versus-Host Disease (GVHD) Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Graft-Versus-Host Disease (GVHD) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Graft-Versus-Host Disease (GVHD) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Graft-Versus-Host Disease (GVHD): Market Segmentation 
FIG. 2 Global Graft-Versus-Host Disease (GVHD) Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Graft-Versus-Host Disease (GVHD) Market, By Product Type, 2019 (US$ Mn) 
FIG. 5 Global Graft-Versus-Host Disease (GVHD) Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Graft-Versus-Host Disease (GVHD) Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Graft-Versus-Host Disease (GVHD) Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Graft-Versus-Host Disease (GVHD) Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Graft-Versus-Host Disease (GVHD) Providers, 2019
FIG. 11 Global Graft-Versus-Host Disease (GVHD) Market Revenue Contribution, By Product Type, 2019 & 2028 (Value %) 
FIG. 12 Global Graft-Versus-Host Disease (GVHD) Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Graft-Versus-Host Disease (GVHD) Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Graft-Versus-Host Disease (GVHD) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Graft-Versus-Host Disease (GVHD) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Graft-Versus-Host Disease (GVHD) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Graft-Versus-Host Disease (GVHD) Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Graft-Versus-Host Disease (GVHD) Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Graft-Versus-Host Disease (GVHD) market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Graft-Versus-Host Disease (GVHD) Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Graft-Versus-Host Disease (GVHD) Market Value, By Segment1, 2018 – 2028
TABLE  North America Graft-Versus-Host Disease (GVHD) Market Value, By Segment2, 2018 – 2028
TABLE  North America Graft-Versus-Host Disease (GVHD) Market Value, By Country, 2018 – 2028
TABLE  Europe Graft-Versus-Host Disease (GVHD) Market Value, By Segment1, 2018 – 2028
TABLE  Europe Graft-Versus-Host Disease (GVHD) Market Value, By Segment2, 2018 – 2028
TABLE  Europe Graft-Versus-Host Disease (GVHD) Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Graft-Versus-Host Disease (GVHD) Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Graft-Versus-Host Disease (GVHD) Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Graft-Versus-Host Disease (GVHD) Market Value, By Country, 2018 – 2028
TABLE  Latin America Graft-Versus-Host Disease (GVHD) Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Graft-Versus-Host Disease (GVHD) Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Graft-Versus-Host Disease (GVHD) Market Value, By Country, 2018 – 2028
TABLE  MEA Graft-Versus-Host Disease (GVHD) Market Value, By Segment1, 2018 – 2028
TABLE  MEA Graft-Versus-Host Disease (GVHD) Market Value, By Segment2, 2018 – 2028
TABLE  MEA Graft-Versus-Host Disease (GVHD) Market Value, By Country, 2018 – 2028
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Astellas Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Graft-Versus-Host Disease (GVHD) Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Graft-Versus-Host Disease (GVHD) Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Graft-Versus-Host Disease (GVHD) Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Graft-Versus-Host Disease (GVHD) Market, By Geography, 2019 (US$ Mn)
FIG.  Global Graft-Versus-Host Disease (GVHD) Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Graft-Versus-Host Disease (GVHD) Providers, 2016
FIG.  Global Graft-Versus-Host Disease (GVHD) Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global ATG therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global IL2Ra Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CD25 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Graft-Versus-Host Disease (GVHD) Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Graft-Versus-Host Disease (GVHD) Market Value, 2018 – 2028, (US$ Mn)